GO:0071751 secretory IgA immunoglobulin complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071751 describes the secretory IgA immunoglobulin complex, a polymeric IgA molecule bound to one chain of secretory component (SC).
• Secretory IgA (sIgA) is the predominant antibody at mucosal surfaces, where it neutralizes pathogens and maintains homeostasis with commensal microbiota.
• Assembly of sIgA requires transcytosis of polymeric IgA across mucosal epithelial cells via the polymeric immunoglobulin receptor (pIgR), with SC remaining bound after cleavage.
• The core structure of sIgA has been resolved, revealing a compact arrangement of IgA dimers and SC that supports high avidity and protease resistance.
• sIgA can modulate immune responses by promoting regulatory T cell differentiation through interactions with dendritic cells and microbiota.
• Research on sIgA spans mucosal immunology, vaccine development, and stress-related immune changes, with methods such as knockout models, knock-in reporters, and CRISPR screening.
Description
The secretory IgA immunoglobulin complex (GO:0071751) is a molecular assembly that serves as the primary antibody defense at mucosal surfaces. It consists of polymeric IgA, typically a dimer, bound to one chain of secretory component (SC), which is a remnant of the polymeric immunoglobulin receptor (pIgR) after transcytosis. This complex is essential for immune exclusion, preventing pathogens from breaching epithelial barriers, and for shaping the composition of the commensal microbiota. Researchers study sIgA to understand mucosal immunity, vaccine responses, and diseases linked to barrier dysfunction. The complex is also a target for therapeutic interventions aiming to enhance mucosal protection.
secretory IgA immunoglobulin complex At A Glance
| GO ID | GO:0071751 |
|---|---|
| GO term | secretory IgA immunoglobulin complex |
| Ontology | cellular_component |
| Synonym | secretory IgA antibody, sIgA1 antibody, sIgA antibody |
| Major function | Mucosal immune defense by neutralizing pathogens and modulating commensal microbiota |
| Components | Polymeric IgA (usually dimer) and secretory component (SC) |
| Assembly | Transcytosis via pIgR, followed by cleavage that leaves SC bound |
| Localization | Mucosal secretions (e.g., saliva, tears, intestinal fluid) |
What Is GO:0071751?
GO:0071751 defines the secretory IgA immunoglobulin complex as a polymeric IgA immunoglobulin complex that is complexed with one chain of secretory component (SC). Polymeric IgA is produced by plasma cells in mucosal tissues and is transported across epithelial cells by the polymeric Ig receptor (pIgR) via transcytosis. During transport, a portion of pIgR is cleaved and remains bound to the IgA as secretory component, forming the secretory IgA complex. This complex is found in mucosal secretions such as saliva, tears, and intestinal fluid, where it performs immune exclusion.
Why Is secretory IgA immunoglobulin complex Important in Cell Biology?
The secretory IgA immunoglobulin complex is critical for maintaining mucosal barrier integrity and protecting against infectious agents. It is the most abundant immunoglobulin in mucosal secretions and plays a key role in immune exclusion, preventing bacterial and viral adherence to epithelial cells. Dysregulation of sIgA production or function is associated with increased susceptibility to infections, inflammatory bowel diseases, and allergies. Moreover, sIgA influences the composition and function of the gut microbiota, thereby impacting systemic immune homeostasis. Understanding sIgA biology is therefore essential for vaccine design, particularly for mucosal pathogens, and for developing therapies that modulate mucosal immunity.
• sIgA is the first line of defense at mucosal surfaces, neutralizing pathogens and toxins.
• It regulates the composition of the commensal microbiota, promoting host-microbe mutualism.
• sIgA deficiency is the most common primary immunodeficiency, leading to recurrent mucosal infections.
• Altered sIgA levels are observed in inflammatory bowel diseases, celiac disease, and allergies.
• sIgA can induce regulatory T cell responses, contributing to immune tolerance.
• Mucosal vaccines often aim to elicit sIgA for protection against enteric and respiratory pathogens.
• Stress and psychosocial factors can influence sIgA reactivity, linking neuroendocrine and immune systems.
• The sIgA complex is a model for studying protein transcytosis and assembly.
• Structural insights into sIgA inform the design of engineered antibodies with enhanced stability.
• sIgA-based therapeutics are being explored for treating mucosal infections and inflammatory conditions.
What Happens During secretory IgA immunoglobulin complex?
Production of polymeric IgA by plasma cells
In simple terms: Plasma cells in mucosal tissues make IgA antibodies that link together into dimers.
Polymeric IgA is produced by plasma cells located in the lamina propria of mucosal tissues. These plasma cells synthesize IgA monomers that assemble into dimers via J chain. The dimeric IgA is then secreted into the interstitial space and binds to the polymeric immunoglobulin receptor (pIgR) on the basolateral surface of epithelial cells.
Transcytosis across epithelial cells via pIgR
In simple terms: The IgA dimer is carried across the epithelial cell by a receptor, like a ferry crossing a river.
The pIgR-IgA complex is internalized into vesicles and transported across the epithelial cell to the apical surface. This process, known as transcytosis, is essential for delivering IgA to mucosal secretions. During transport, the complex remains intact and is protected from degradation.
Cleavage of pIgR and formation of secretory component
In simple terms: After reaching the surface, the receptor is cut, and a piece of it stays attached to IgA, forming the secretory component.
At the apical surface, the extracellular portion of pIgR is cleaved by proteases, releasing the IgA dimer still bound to a fragment of the receptor. This fragment is called secretory component (SC). The resulting complex is secretory IgA (sIgA), which is now free in mucosal secretions.
Function of sIgA in mucosal immunity
In simple terms: The finished sIgA acts like a shield, sticking to microbes and preventing them from entering the body.
Secretory IgA neutralizes pathogens by binding to their surface antigens, preventing adhesion to epithelial cells. It also agglutinates bacteria and facilitates their clearance by mucus flow. Additionally, sIgA can interact with dendritic cells to promote regulatory T cell differentiation, contributing to immune tolerance.
Structural features of the sIgA core
In simple terms: The sIgA complex has a specific shape that makes it stable and effective in harsh mucosal environments.
The core structure of sIgA has been determined by cryo-EM, revealing a compact arrangement of two IgA monomers and one SC molecule. The SC wraps around the IgA dimer, providing protection against proteolytic degradation and enhancing stability in mucosal secretions.
Key Genes Involved in GO:0071751 secretory IgA immunoglobulin complex
The following genes and proteins are central to the biology of the secretory IgA immunoglobulin complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IGHA1 | Encodes IgA1 heavy chain | Major component of sIgA; mutations linked to IgA deficiency |
| IGHA2 | Encodes IgA2 heavy chain | More resistant to bacterial proteases; important in gut immunity |
| IGKC | Encodes immunoglobulin kappa light chain | Forms light chains of IgA; affects antibody specificity |
| IGLC1 | Encodes immunoglobulin lambda light chain | Alternative light chain; contributes to IgA diversity |
| JCHAIN | Joining chain for IgA dimerization | Essential for polymeric IgA formation and pIgR binding |
| PIGR | Polymeric immunoglobulin receptor | Mediates transcytosis and provides secretory component |
| TNFRSF13B | Transmembrane activator and CAML interactor (TACI) | Regulates IgA class switching; mutations cause IgA deficiency |
| CD40LG | CD40 ligand | Costimulates B cells for IgA production; defects lead to hyper-IgM syndrome |
| AICDA | Activation-induced cytidine deaminase | Required for class switch recombination to IgA |
| PRDM1 | Blimp-1 | Transcription factor driving plasma cell differentiation for IgA secretion |
| XBP1 | X-box binding protein 1 | Regulates plasma cell development and IgA secretion |
| IRF4 | Interferon regulatory factor 4 | Controls plasma cell differentiation and IgA production |
| TGFB1 | Transforming growth factor beta 1 | Induces IgA class switching in B cells |
| IL10 | Interleukin 10 | Promotes IgA production and regulatory T cell responses |
| RETNLB | Resistin-like beta | Secreted by goblet cells; promotes IgA production in gut |
| CCL28 | C-C motif chemokine ligand 28 | Attracts IgA plasma cells to mucosal tissues |
| MADCAM1 | Mucosal addressin cell adhesion molecule 1 | Mediates homing of IgA plasma cells to gut |
How Is secretory IgA immunoglobulin complex Regulated?
The production and assembly of secretory IgA are regulated at multiple levels. TGF-β1 and IL-10 promote IgA class switching and plasma cell differentiation. The polymeric immunoglobulin receptor (pIgR) expression is upregulated by cytokines such as IFN-γ and TNF-α, enhancing transcytosis. Additionally, microbial signals through Toll-like receptors can modulate pIgR expression and IgA secretion. Stress-related factors, such as psychosocial stress, can influence sIgA reactivity, as shown in children and adolescents. These regulatory mechanisms ensure that sIgA production is tailored to the mucosal environment.
secretory IgA immunoglobulin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGR | IgA nephropathy; mucosal infections | Pigr knockout mouse |
| TNFRSF13B | Common variable immunodeficiency; IgA deficiency | Tnfrsf13b knockout mouse |
| AICDA | Hyper-IgM syndrome; IgA deficiency | Aicda knockout mouse |
| TGFB1 | Inflammatory bowel disease; IgA deficiency | Tgfb1 knockout mouse |
| IL10 | Inflammatory bowel disease; colitis | Il10 knockout mouse |
Secretory IgA deficiency and mucosal infections
Selective IgA deficiency is the most common primary immunodeficiency, characterized by low or absent serum and mucosal IgA. Individuals with this condition suffer from recurrent respiratory and gastrointestinal infections. Defects in genes such as TNFRSF13B, CD40LG, and AICDA can lead to impaired IgA production. Understanding the assembly of the sIgA complex is crucial for developing replacement therapies.
Inflammatory bowel disease and dysbiosis
Altered sIgA levels and function are associated with inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. sIgA helps maintain homeostasis with the gut microbiota, and its deficiency can lead to dysbiosis and exacerbated inflammation. The interaction of sIgA with commensal bacteria, such as Lactobacillus rhamnosus, can promote regulatory T cell responses, which are protective in IBD.
Vaccine development and mucosal immunity
Mucosal vaccines aim to induce sIgA responses to protect against enteric and respiratory pathogens. The sIgA complex is a key effector of vaccine-induced immunity, and understanding its structure and function can guide vaccine design. For example, vaccines against rotavirus and poliovirus rely on sIgA for protection.
Stress and neuroendocrine-immune interactions
Psychosocial stress can modulate sIgA levels, as demonstrated in studies of children and adolescents. sIgA reactivity to acute stress is influenced by pubertal development and history of maltreatment, highlighting the interplay between the nervous and mucosal immune systems.
From secretory IgA immunoglobulin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of pIgR in sIgA transcytosis? | Pigr knockout mouse or epithelial cell line |
| How does SC protect IgA from degradation? | Knock-in of tagged SC in cell lines |
| What is the effect of IgA deficiency on microbiota? | IgA knockout mouse (Igha-/-) |
| Can sIgA modulate Treg differentiation? | Overexpression of sIgA in dendritic cell co-cultures |
| How does stress affect sIgA levels? | Point mutation in stress-related genes in mouse models |
| What is the structural basis of sIgA assembly? | Knock-in of fluorescent tags for cryo-EM |
How to Study the secretory IgA immunoglobulin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | High-resolution structure of sIgA | Understanding assembly and stability |
| ELISA | sIgA concentration in secretions | Diagnosis of IgA deficiency; stress studies |
| Transcytosis assay | Transport of IgA across epithelial cells | Studying pIgR function |
| Flow cytometry | Surface pIgR expression | Regulation of receptor levels |
| Co-culture assays | Treg differentiation induced by sIgA | Immunomodulatory mechanisms |
| 16S rRNA sequencing | Microbiota composition | Impact of sIgA on gut flora |
| CRISPR screening | Genes required for sIgA production | Identifying novel regulators |
Structural analysis by cryo-EM
Cryo-electron microscopy has been used to solve the core structure of sIgA, revealing the arrangement of IgA dimers and SC. This method provides high-resolution insights into the assembly and stability of the complex.
Transcytosis assays
In vitro transcytosis assays using polarized epithelial cell monolayers can measure the transport of polymeric IgA from the basolateral to apical side. These assays are useful for studying pIgR function and regulation.
Mucosal secretion analysis
sIgA levels in saliva, tears, and intestinal lavage can be quantified by ELISA. Such analyses are used to assess mucosal immunity in health and disease, including stress studies.
Microbiota interaction studies
Co-culture of sIgA with commensal bacteria and dendritic cells can reveal immunomodulatory effects, such as Treg induction. These studies help elucidate the role of sIgA in maintaining gut homeostasis.
How CRISPR Can Be Used to Study GO:0071751 secretory IgA immunoglobulin complex
Knockout
CRISPR knockout of genes such as PIGR, JCHAIN, or IGHA1 can abolish sIgA production and transcytosis, providing models to study the consequences of sIgA deficiency in mucosal immunity.
Point Mutation
Introducing point mutations in the pIgR cleavage site or in IgA hinge regions can reveal residues critical for SC binding and stability. Such models help dissect the molecular interactions within the sIgA complex.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the PIGR or IGHA1 locus allows real-time tracking of sIgA transcytosis and secretion in live cells. This approach is valuable for imaging studies.
Overexpression
Overexpression of sIgA components or regulatory cytokines (e.g., TGFB1, IL10) in cell lines or mouse models can enhance sIgA production and facilitate studies on its immunomodulatory functions.
How EDITGENE Supports secretory IgA immunoglobulin complex Research
Researchers studying secretory IgA immunoglobulin complex-related genes often need to determine whether a candidate gene is causally involved in sIgA assembly, transport, or function. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for secretory IgA immunoglobulin complex research.
Frequently Asked Questions About secretory IgA immunoglobulin complex
What is the secretory IgA immunoglobulin complex?
It is a polymeric IgA molecule bound to secretory component, forming the primary antibody defense at mucosal surfaces.
What genes are involved in secretory IgA immunoglobulin complex?
Key genes include IGHA1, IGHA2, JCHAIN, PIGR, and regulators like TGFB1 and IL10.
How is secretory IgA transported across epithelial cells?
It is transported via transcytosis mediated by the polymeric immunoglobulin receptor (pIgR).
What is the role of secretory component in sIgA?
Secretory component is a fragment of pIgR that remains bound to IgA, protecting it from degradation and enhancing stability.
What diseases are associated with sIgA deficiency?
Selective IgA deficiency, inflammatory bowel disease, and recurrent mucosal infections.
How can I study sIgA using CRISPR?
CRISPR knockout, knock-in, or overexpression of genes like PIGR and JCHAIN can model sIgA function in vitro and in vivo.
What methods are used to measure sIgA?
ELISA, transcytosis assays, cryo-EM, and flow cytometry are commonly used.
Does stress affect sIgA levels?
Yes, psychosocial stress can modulate sIgA reactivity, especially in children and adolescents.
What is the structure of sIgA?
The core structure consists of two IgA monomers and one secretory component, resolved by cryo-EM.
How does sIgA interact with gut microbiota?
sIgA binds to commensal bacteria and can promote regulatory T cell responses, maintaining homeostasis.
Conclusion
The secretory IgA immunoglobulin complex (GO:0071751) is a cornerstone of mucosal immunity, providing protection against pathogens and maintaining harmony with the microbiota. Its assembly via pIgR-mediated transcytosis and the retention of secretory component are critical for its stability and function. Advances in structural biology and CRISPR-based models continue to unravel the complexities of sIgA biology, offering new avenues for vaccine development and therapies for mucosal diseases. Researchers can leverage EDITGENE's services to create tailored models for studying sIgA-related genes and mechanisms.
References
- 1. Marques-Feixa L et al.. 2022. Secretory immunoglobulin A (s-IgA) reactivity to acute psychosocial stress in children and adolescents: The influence of pubertal development and history of maltreatment.. Brain Behav Immun 103:122-129 PMID: 35427757
- 2. Asano M et al.. 2011. Polymeric immunoglobulin receptor.. J Oral Sci 53(2):147-56 PMID: 21712618
- 3. Kumar N et al.. 2020. Structure of the secretory immunoglobulin A core.. Science 367(6481):1008-1014 PMID: 32029686
- 4. Mikulic J et al.. 2017. Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-β.. Cell Mol Immunol 14(6):546-556 PMID: 26972771
- 5. Brandtzaeg P. 1981. Transport models for secretory IgA and secretory IgM.. Clin Exp Immunol 44(2):221-32 PMID: 6118214
- 7. Corthésy B et al.. 1999. Secretory immunoglobulin A: from mucosal protection to vaccine development.. Biol Chem 380(11):1251-62 PMID: 10614817
- 8. Mantis NJ et al.. 2011. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.. Mucosal Immunol 4(6):603-11 PMID: 21975936
